(S)-AMPA increases expression EXP 6480464 alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid results in increased expression of HNRNPAB protein CTD PMID:21471000 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:730897 6480464 o, p'-DDT results in increased expression of HNRNPAB mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of HNRNPAB mRNA CTD PMID:24096037 1,2-dimethylhydrazine multiple interactions ISO RGD:730897 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPAB mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression ISO RGD:730897 6480464 1, 2-Dimethylhydrazine affects the expression of HNRNPAB mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:730897 6480464 Ethinyl Estradiol affects the expression of HNRNPAB mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HNRNPAB mRNA CTD PMID:16174780 more ... 17alpha-ethynylestradiol increases expression ISO RGD:730897 6480464 Ethinyl Estradiol results in increased expression of HNRNPAB mRNA CTD PMID:16174780 more ... 17alpha-ethynylestradiol multiple interactions ISO RGD:730897 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPAB mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:730896 6480464 Estradiol results in increased expression of HNRNPAB mRNA CTD PMID:14605097 , PMID:31614463 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of HNRNPAB mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:730897 6480464 Tetrachlorodibenzodioxin results in decreased expression of HNRNPAB mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HNRNPAB mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:730897 6480464 Tetrachlorodibenzodioxin results in increased expression of HNRNPAB mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:730897 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPAB mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:730897 6480464 Tetrachlorodibenzodioxin affects the expression of HNRNPAB mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of HNRNPAB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HNRNPAB mRNA CTD PMID:21346803 3',5'-cyclic UMP affects binding ISO RGD:730896 6480464 HNRNPAB protein binds to cyclic 3', 5'-uridine monophosphate CTD PMID:30528433 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:730896 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HNRNPAB mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HNRNPAB mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:730897 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of HNRNPAB mRNA CTD PMID:18648102 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of HNRNPAB mRNA CTD PMID:24780913 , PMID:30047161 acrolein multiple interactions ISO RGD:730896 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of HNRNPAB mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of HNRNPAB mRNA CTD PMID:32699268 afimoxifene multiple interactions ISO RGD:730896 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of HNRNPAB mRNA] CTD PMID:21233418 aflatoxin B1 decreases expression ISO RGD:730897 6480464 Aflatoxin B1 results in decreased expression of HNRNPAB mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:730896 6480464 Aflatoxin B1 results in increased expression of HNRNPAB mRNA CTD PMID:22100608 , PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:730896 6480464 [Tretinoin co-treated with Tamoxifen] results in decreased expression of HNRNPAB protein CTD PMID:17098229 all-trans-retinoic acid decreases expression ISO RGD:730896 6480464 Tretinoin results in decreased expression of HNRNPAB protein CTD PMID:17098229 alpha-pinene multiple interactions ISO RGD:730896 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of HNRNPAB mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of HNRNPAB mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of HNRNPAB mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HNRNPAB mRNA CTD PMID:16483693 Aroclor 1254 decreases expression ISO RGD:730897 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HNRNPAB mRNA CTD PMID:23650126 benzo[a]pyrene increases expression ISO RGD:730897 6480464 Benzo(a)pyrene results in increased expression of HNRNPAB mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:730896 6480464 Benzo(a)pyrene results in increased methylation of HNRNPAB promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of HNRNPAB mRNA CTD PMID:21839799 bis(2-chloroethyl) sulfide decreases expression ISO RGD:730896 6480464 Mustard Gas results in decreased expression of HNRNPAB mRNA CTD PMID:25102026 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HNRNPAB mRNA CTD PMID:25181051 more ... bisphenol A decreases expression ISO RGD:730897 6480464 bisphenol A results in decreased expression of HNRNPAB mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HNRNPAB protein CTD PMID:32145629 bisphenol A decreases expression ISO RGD:730896 6480464 bisphenol A results in decreased expression of HNRNPAB mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:730896 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HNRNPAB mRNA CTD PMID:28628672 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of HNRNPAB gene, [bisphenol A co-treated with Genistein] results in increased methylation of HNRNPAB gene CTD PMID:28505145 bisphenol A affects methylation ISO RGD:730897 6480464 bisphenol A affects the methylation of HNRNPAB promoter CTD PMID:27334623 bisphenol F multiple interactions ISO RGD:730896 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HNRNPAB mRNA CTD PMID:28628672 bleomycin A5 increases expression ISO RGD:730896 6480464 bleomycetin results in increased expression of HNRNPAB mRNA CTD PMID:21040473 cadmium atom multiple interactions ISO RGD:730896 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HNRNPAB mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:730896 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HNRNPAB mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:730896 6480464 Caffeine results in decreased phosphorylation of HNRNPAB protein CTD PMID:35688186 carbon nanotube increases expression ISO RGD:730897 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloropicrin affects expression ISO RGD:730896 6480464 chloropicrin affects the expression of HNRNPAB mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:730897 6480464 Chlorpyrifos results in decreased expression of HNRNPAB mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:730897 6480464 chromium hexavalent ion affects the expression of HNRNPAB mRNA CTD PMID:28472532 chrysene increases expression ISO RGD:730897 6480464 chrysene results in increased expression of HNRNPAB mRNA CTD PMID:26377693 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of HNRNPAB protein CTD PMID:22023808 cobalt dichloride decreases expression ISO RGD:730896 6480464 cobaltous chloride results in decreased expression of HNRNPAB mRNA CTD PMID:19320972 copper atom decreases expression ISO RGD:730897 6480464 Copper results in decreased expression of HNRNPAB protein CTD PMID:21146535 copper(0) decreases expression ISO RGD:730897 6480464 Copper results in decreased expression of HNRNPAB protein CTD PMID:21146535 crocidolite asbestos decreases expression ISO RGD:730897 6480464 Asbestos, Crocidolite results in decreased expression of HNRNPAB mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:730896 6480464 Cyclosporine results in decreased expression of HNRNPAB mRNA CTD PMID:21163907 decabromodiphenyl ether increases expression ISO RGD:730897 6480464 decabromobiphenyl ether results in increased expression of HNRNPAB mRNA CTD PMID:29699156 dexamethasone multiple interactions ISO RGD:730896 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HNRNPAB mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HNRNPAB mRNA CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of HNRNPAB mRNA CTD PMID:17379624 dibutyl phthalate decreases expression ISO RGD:730897 6480464 Dibutyl Phthalate results in decreased expression of HNRNPAB mRNA CTD PMID:21266533 dioxygen decreases expression ISO RGD:730896 6480464 Oxygen deficiency results in decreased expression of HNRNPAB mRNA CTD PMID:26516004 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HNRNPAB mRNA CTD PMID:33729688 enzyme inhibitor multiple interactions ISO RGD:730896 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HNRNPAB protein CTD PMID:23301498 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of HNRNPAB mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HNRNPAB mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:730897 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPAB mRNA CTD PMID:22206623 genistein decreases methylation EXP 6480464 Genistein results in decreased methylation of HNRNPAB gene CTD PMID:28505145 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of HNRNPAB gene, [bisphenol A co-treated with Genistein] results in increased methylation of HNRNPAB gene CTD PMID:28505145 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HNRNPAB mRNA CTD PMID:22061828 geraniol decreases expression ISO RGD:730896 6480464 geraniol results in decreased expression of HNRNPAB mRNA CTD PMID:27683099 hydrogen cyanide increases expression ISO RGD:730897 6480464 Hydrogen Cyanide results in increased expression of HNRNPAB mRNA CTD PMID:33914522 hydrogen peroxide affects expression ISO RGD:730896 6480464 Hydrogen Peroxide affects the expression of HNRNPAB mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:730896 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HNRNPAB mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HNRNPAB mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:730896 6480464 Ivermectin results in decreased expression of HNRNPAB protein CTD PMID:32959892 lipopolysaccharide multiple interactions ISO RGD:730896 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of HNRNPAB mRNA CTD PMID:35877022 lovastatin increases expression ISO RGD:730897 6480464 Lovastatin results in increased expression of HNRNPAB mRNA CTD PMID:20493250 methimazole increases expression EXP 6480464 Methimazole results in increased expression of HNRNPAB mRNA CTD PMID:30047161 methotrexate decreases expression ISO RGD:730896 6480464 Methotrexate results in decreased expression of HNRNPAB mRNA CTD PMID:24449571 methylseleninic acid decreases expression ISO RGD:730896 6480464 methylselenic acid results in decreased expression of HNRNPAB mRNA CTD PMID:18548127 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of HNRNPAB mRNA CTD PMID:24136188 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of HNRNPAB mRNA CTD PMID:23439660 ozone multiple interactions ISO RGD:730896 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of HNRNPAB mRNA more ... CTD PMID:32699268 paclitaxel decreases expression ISO RGD:730896 6480464 Paclitaxel results in decreased expression of HNRNPAB mRNA CTD PMID:15000894 paracetamol increases expression ISO RGD:730896 6480464 Acetaminophen results in increased expression of HNRNPAB protein CTD PMID:22230336 paracetamol affects expression ISO RGD:730897 6480464 Acetaminophen affects the expression of HNRNPAB mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:730896 6480464 Acetaminophen results in decreased expression of HNRNPAB protein CTD PMID:22230336 paraquat increases expression EXP 6480464 Paraquat results in increased expression of HNRNPAB mRNA CTD PMID:32680482 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HNRNPAB mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:730897 6480464 Phenobarbital affects the expression of HNRNPAB mRNA CTD PMID:23091169 potassium cyanide increases expression ISO RGD:730897 6480464 Potassium Cyanide results in increased expression of HNRNPAB mRNA CTD PMID:33914522 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of HNRNPAB mRNA CTD PMID:30047161 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of HNRNPAB mRNA CTD PMID:20726854 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of HNRNPAB mRNA CTD PMID:30047161 quartz increases expression ISO RGD:730896 6480464 Quartz results in increased expression of HNRNPAB protein CTD PMID:27917503 resveratrol decreases expression ISO RGD:730897 6480464 resveratrol results in decreased expression of HNRNPAB protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:730896 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPAB mRNA CTD PMID:23557933 silicon dioxide decreases expression ISO RGD:730896 6480464 Silicon Dioxide results in decreased expression of HNRNPAB protein CTD PMID:27917503 sodium arsenite increases expression ISO RGD:730896 6480464 sodium arsenite results in increased expression of HNRNPAB mRNA CTD PMID:28595984 , PMID:34032870 sodium dodecyl sulfate decreases expression ISO RGD:730896 6480464 Sodium Dodecyl Sulfate results in decreased expression of HNRNPAB protein CTD PMID:21469165 sodium fluoride increases expression ISO RGD:730897 6480464 Sodium Fluoride results in increased expression of HNRNPAB mRNA CTD PMID:27862939 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of HNRNPAB mRNA CTD PMID:30047161 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of HNRNPAB protein CTD PMID:26141394 tamoxifen decreases expression ISO RGD:730896 6480464 Tamoxifen results in decreased expression of HNRNPAB protein CTD PMID:17098229 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of HNRNPAB mRNA CTD PMID:19400957 tamoxifen increases expression ISO RGD:730897 6480464 Tamoxifen results in increased expression of HNRNPAB mRNA CTD PMID:19400957 tamoxifen affects expression ISO RGD:730897 6480464 Tamoxifen affects the expression of HNRNPAB mRNA CTD PMID:17555576 tamoxifen multiple interactions ISO RGD:730896 6480464 [Tretinoin co-treated with Tamoxifen] results in decreased expression of HNRNPAB protein CTD PMID:17098229 temozolomide increases expression ISO RGD:730896 6480464 Temozolomide results in increased expression of HNRNPAB mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:730897 6480464 Carbon Tetrachloride results in increased expression of HNRNPAB mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HNRNPAB mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HNRNPAB mRNA CTD PMID:34492290 trichloroethene increases expression ISO RGD:730897 6480464 Trichloroethylene results in increased expression of HNRNPAB mRNA CTD PMID:19448997 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of HNRNPAB mRNA CTD PMID:33387578 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of HNRNPAB gene CTD PMID:27618143 trichostatin A affects expression ISO RGD:730896 6480464 trichostatin A affects the expression of HNRNPAB mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO RGD:730897 6480464 trimellitic anhydride results in increased expression of HNRNPAB mRNA CTD PMID:19042947 valproic acid decreases expression ISO RGD:730896 6480464 Valproic Acid results in decreased expression of HNRNPAB mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:730897 6480464 Valproic Acid affects the expression of HNRNPAB mRNA CTD PMID:17292431 warfarin increases expression ISO RGD:730897 6480464 Warfarin results in increased expression of HNRNPAB mRNA CTD PMID:20493250
